01GT20029 for Hair Loss in Men: What the Trial Data Show So Far
GT20029 is an investigational topical that destroys the androgen receptor in the scalp instead of blocking it. One 12-week phase 2 trial in 180 men is the entire efficacy record, and it is thinner than the headlines suggest.













